WEBSITE BSE:544205 NSE: NPL Inc. Year: 2020 Industry: Chemicals My Bucket: Add Stock
Last updated: 10:55
National Peroxide Limited (NPL) is a leading manufacturer in India, specializing in hydrogen peroxide, compressed hydrogen gas, and peracetic acid. Founded as a joint venture between The Bombay Dyeing & Manufacturing Company and Laporte Industries, NPL has grown to become the largest producer of hydrogen peroxide in the country. The company’s integrated manufacturing site is located in Maharashtra, with a capacity of 150,000 Metric Tons Per Annum (MTPA) on a 50% w/w basis. Serves to a wide range of industries including non-edible oil ref...Read More
National Peroxide Limited (NPL) is a leading manufacturer in India, specializing in hydrogen peroxide, compressed hydrogen gas, and peracetic acid. Founded as a joint venture between The Bombay Dyeing & Manufacturing Company and Laporte Industries, NPL has grown to become the largest producer of hydrogen peroxide in the country. The company’s integrated manufacturing site is located in Maharashtra, with a capacity of 150,000 Metric Tons Per Annum (MTPA) on a 50% w/w basis. Serves to a wide range of industries including non-edible oil refining, water and effluent treatment, paper-pulp bleaching, chemical synthesis, textile bleaching, sugar bleaching, and metallurgy. NPL is committed to environmental sustainability and safety, holding certifications like RC 14001-2015, ISO 14001-2015, and ISO 45001-2018. These standards reflect the company’s dedication to responsible manufacturing practices and occupational health and safety management ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹230 Cr.
Stock P/E -102.5
P/B 0.7
Current Price ₹400.6
Book Value ₹ 613.1
Face Value 10
52W High ₹770
Dividend Yield 0%
52W Low ₹ 350
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 82 | 84 | 88 | 74 | 77 | 62 | 74 | 67 | 68 | 69 |
| Other Income | 2 | 1 | 0 | 2 | 2 | 0 | 0 | 2 | 2 | 1 |
| Total Income | 84 | 85 | 88 | 76 | 79 | 63 | 74 | 69 | 70 | 70 |
| Total Expenditure | 73 | 74 | 79 | 64 | 73 | 59 | 76 | 62 | 64 | 62 |
| Operating Profit | 11 | 11 | 9 | 12 | 6 | 4 | -2 | 7 | 6 | 8 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Profit Before Tax | 6 | 5 | 4 | 7 | 1 | -2 | -8 | 1 | 1 | 2 |
| Provision for Tax | 2 | 1 | 1 | 2 | 0 | -0 | -1 | 0 | 0 | -0 |
| Profit After Tax | 4 | 5 | 3 | 5 | 1 | -2 | -6 | 1 | 0 | 2 |
| Adjustments | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 4 | 5 | 3 | 5 | 1 | -2 | -6 | 1 | 0 | 2 |
| Adjusted Earnings Per Share | 7.7 | 8.3 | 5.3 | 8.8 | 1.2 | -2.6 | -11.3 | 1.5 | 0.7 | 3.2 |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Net Sales | 377 | 333 | 287 | 278 |
| Other Income | 8 | 6 | 4 | 5 |
| Total Income | 385 | 339 | 291 | 283 |
| Total Expenditure | 317 | 296 | 272 | 264 |
| Operating Profit | 67 | 43 | 20 | 19 |
| Interest | 7 | 2 | 2 | 0 |
| Depreciation | 20 | 19 | 20 | 20 |
| Exceptional Income / Expenses | 13 | 0 | 0 | -1 |
| Profit Before Tax | 54 | 22 | -2 | -4 |
| Provision for Tax | 14 | 5 | 0 | -1 |
| Profit After Tax | 40 | 17 | -2 | -3 |
| Adjustments | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 40 | 17 | -2 | -3 |
| Adjusted Earnings Per Share | 0 | 29.2 | -3.9 | -5.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -14% | 0% | 0% | 0% |
| Operating Profit CAGR | -53% | 0% | 0% | 0% |
| PAT CAGR | -112% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -37% | NA% | NA% | NA% |
| ROE Average | -1% | 5% | 5% | 5% |
| ROCE Average | -0% | 8% | 8% | 8% |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Shareholder's Funds | 352 | 359 | 349 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 10 | 7 | 4 |
| Other Non-Current Liabilities | 51 | 63 | 64 |
| Total Current Liabilities | 48 | 41 | 37 |
| Total Liabilities | 461 | 470 | 453 |
| Fixed Assets | 336 | 321 | 312 |
| Other Non-Current Assets | 4 | 29 | 20 |
| Total Current Assets | 121 | 120 | 121 |
| Total Assets | 461 | 470 | 453 |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 6 | 9 |
| Cash Flow from Operating Activities | 67 | 36 | 19 |
| Cash Flow from Investing Activities | 25 | -18 | -2 |
| Cash Flow from Financing Activities | -86 | -17 | -13 |
| Net Cash Inflow / Outflow | 6 | 2 | 4 |
| Closing Cash & Cash Equivalent | 6 | 9 | 13 |
| # | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 29.22 | -3.91 |
| CEPS(Rs) | 0 | 62.73 | 31.08 |
| DPS(Rs) | 0 | 12.5 | 0 |
| Book NAV/Share(Rs) | 0 | 624.61 | 607.73 |
| Core EBITDA Margin(%) | 14.8 | 10.23 | 4.84 |
| EBIT Margin(%) | 14.99 | 6.51 | -0.13 |
| Pre Tax Margin(%) | 13.26 | 5.96 | -0.66 |
| PAT Margin (%) | 9.79 | 4.65 | -0.71 |
| Cash Profit Margin (%) | 14.69 | 9.98 | 5.68 |
| ROA(%) | 8.56 | 3.61 | -0.49 |
| ROE(%) | 11.41 | 4.76 | -0.63 |
| ROCE(%) | 16.54 | 6.39 | -0.11 |
| Receivable days | 21.94 | 25.99 | 28.99 |
| Inventory Days | 32.69 | 35.38 | 38.5 |
| Payable days | 46.48 | 51.54 | 51.87 |
| PER(x) | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0.95 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.02 | -0 | 1.1 |
| EV/Core EBITDA(x) | 0.1 | -0.02 | 15.99 |
| Net Sales Growth(%) | 0 | -11.7 | -13.85 |
| EBIT Growth(%) | 0 | -61.18 | -101.75 |
| PAT Growth(%) | 0 | -57.49 | -113.38 |
| EPS Growth(%) | 0 | 0 | -113.38 |
| Debt/Equity(x) | 0.04 | 0.03 | 0.02 |
| Current Ratio(x) | 2.51 | 2.94 | 3.3 |
| Quick Ratio(x) | 1.76 | 2.11 | 2.41 |
| Interest Cover(x) | 8.62 | 11.86 | -0.25 |
| Total Debt/Mcap(x) | 0 | 0 | 0.02 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Promoter | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 |
| FII | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 29.16 | 29.23 | 29.23 | 29.23 | 29.23 | 29.23 | 29.23 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Promoter | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
